Overall, regarding BC phenotypes, we found 63 cases (45%) HR+HER2−, 11 cases (7.9%) HR+HER2+, 22 cases (15.7%) HER2+ and 44 cases (31.4%) TN. Here, ERBB2 is linked to breast cancer.